| __timestamp | Arrowhead Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 2819557000 |
| Thursday, January 1, 2015 | 382000 | 4103728000 |
| Friday, January 1, 2016 | 158333 | 4860427000 |
| Sunday, January 1, 2017 | 31407709 | 5872227000 |
| Monday, January 1, 2018 | 16142321 | 6710800000 |
| Tuesday, January 1, 2019 | 168795577 | 7863400000 |
| Wednesday, January 1, 2020 | 87992066 | 8497100000 |
| Friday, January 1, 2021 | 138287000 | 16071700000 |
| Saturday, January 1, 2022 | 243231000 | 12172900000 |
| Sunday, January 1, 2023 | 240735000 | 13117200000 |
| Monday, January 1, 2024 | 3551000 | 14202000000 |
Cracking the code
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed Arrowhead Pharmaceuticals, Inc. in terms of revenue. From 2014 to 2023, Regeneron's revenue surged by over 360%, peaking at approximately $13.1 billion in 2023. In contrast, Arrowhead's revenue, while growing, remains a fraction of Regeneron's, with its highest recorded revenue being around $243 million in 2022.
Regeneron's impressive growth can be attributed to its robust pipeline and successful product launches, while Arrowhead is still in the early stages of capitalizing on its innovative RNAi technology. As we look to the future, the question remains: can Arrowhead close the gap, or will Regeneron continue to dominate the biotech revenue landscape?
Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: AstraZeneca PLC and Regeneron Pharmaceuticals, Inc. Performance Compared
Revenue Insights: AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: Pfizer Inc. vs Regeneron Pharmaceuticals, Inc.
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Zoetis Inc. vs Arrowhead Pharmaceuticals, Inc.
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Amneal Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
PTC Therapeutics, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Arrowhead Pharmaceuticals, Inc. vs Xencor, Inc.